123 related articles for article (PubMed ID: 34768086)
1. Development of a novel senolytic by precise disruption of FOXO4-p53 complex.
Tripathi U; Chaib S; Gerdes EOW; Hogan KA; Zhu Y
EBioMedicine; 2021 Dec; 74():103693. PubMed ID: 34768086
[No Abstract] [Full Text] [Related]
2. Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells.
Le HH; Cinaroglu SS; Manalo EC; Ors A; Gomes MM; Duan Sahbaz B; Bonic K; Origel Marmolejo CA; Quentel A; Plaut JS; Kawashima TE; Ozdemir ES; Malhotra SV; Ahiska Y; Sezerman U; Bayram Akcapinar G; Saldivar JC; Timucin E; Fischer JM
EBioMedicine; 2021 Nov; 73():103646. PubMed ID: 34689087
[TBL] [Abstract][Full Text] [Related]
3. FOXO4 interacts with p53 TAD and CRD and inhibits its binding to DNA.
Mandal R; Kohoutova K; Petrvalska O; Horvath M; Srb P; Veverka V; Obsilova V; Obsil T
Protein Sci; 2022 May; 31(5):e4287. PubMed ID: 35481640
[TBL] [Abstract][Full Text] [Related]
4. Biophysical investigation of the dual binding surfaces of human transcription factors FOXO4 and p53.
Kim J; Ahn D; Park CJ
FEBS J; 2022 Jun; 289(11):3163-3182. PubMed ID: 34954873
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cellular senescence via the FOXO4-p53 axis.
Bourgeois B; Madl T
FEBS Lett; 2018 Jun; 592(12):2083-2097. PubMed ID: 29683489
[TBL] [Abstract][Full Text] [Related]
6. FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage.
Chung YM; Park SH; Tsai WB; Wang SY; Ikeda MA; Berek JS; Chen DJ; Hu MC
Nat Commun; 2012; 3():1000. PubMed ID: 22893124
[TBL] [Abstract][Full Text] [Related]
7. Forkhead box O4 transcription factor in human neoplasms: Cannot afford to lose the novel suppressor.
Lu C; Yang Z; Jiang S; Yang Y; Han Y; Lv J; Li T; Chen F; Yu Y
J Cell Physiol; 2019 Jun; 234(6):8647-8658. PubMed ID: 30515801
[TBL] [Abstract][Full Text] [Related]
8. Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress.
Hori YS; Kuno A; Hosoda R; Horio Y
PLoS One; 2013; 8(9):e73875. PubMed ID: 24040102
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of ribosomal protein S27-like confers radiosensitivity via the Mdm2-p53 and Mdm2-MRN-ATM axes.
Zhao Y; Tan M; Liu X; Xiong X; Sun Y
Cell Death Dis; 2018 Feb; 9(2):145. PubMed ID: 29396424
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Brd4 alleviates renal ischemia/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress.
Liu H; Wang L; Weng X; Chen H; Du Y; Diao C; Chen Z; Liu X
Redox Biol; 2019 Jun; 24():101195. PubMed ID: 31004990
[TBL] [Abstract][Full Text] [Related]
11. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity.
Qi W; Weber CR; Wasland K; Savkovic SD
BMC Cancer; 2011 Jun; 11():219. PubMed ID: 21639915
[TBL] [Abstract][Full Text] [Related]
12. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
13. The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function.
Lo PK; Lee JS; Sukumar S
Cell Signal; 2012 Jan; 24(1):316-24. PubMed ID: 21964066
[TBL] [Abstract][Full Text] [Related]
14. FOXN3 inhibits cell proliferation and invasion via modulating the AKT/MDM2/p53 axis in human glioma.
Wang C; Tu H; Yang L; Ma C; Hu J; Luo J; Wang H
Aging (Albany NY); 2021 Sep; 13(17):21587-21598. PubMed ID: 34511432
[TBL] [Abstract][Full Text] [Related]
15. Correlations of ALD, Keap-1, and FoxO4 expression with traditional tumor markers and clinicopathological characteristics in colorectal carcinoma.
Huang P; Wang S; Wu Z; Zhou Z; Kuang M; Ren C; Qian X; Jiang A; Zhou Y; Wang X; Shao G
Medicine (Baltimore); 2022 Aug; 101(34):e30222. PubMed ID: 36042628
[TBL] [Abstract][Full Text] [Related]
16. A novel role for p73 in the regulation of Akt-Foxo1a-Bim signaling and apoptosis induced by the plant lectin, Concanavalin A.
Amin AR; Paul RK; Thakur VS; Agarwal ML
Cancer Res; 2007 Jun; 67(12):5617-21. PubMed ID: 17575126
[TBL] [Abstract][Full Text] [Related]
17. The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs.
Di Agostino S; Cortese G; Monti O; Dell'Orso S; Sacchi A; Eisenstein M; Citro G; Strano S; Blandino G
Cell Cycle; 2008 Nov; 7(21):3440-7. PubMed ID: 18948736
[TBL] [Abstract][Full Text] [Related]
18. Multiple regulatory intrinsically disordered motifs control FOXO4 transcription factor binding and function.
Bourgeois B; Gui T; Hoogeboom D; Hocking HG; Richter G; Spreitzer E; Viertler M; Richter K; Madl T; Burgering BMT
Cell Rep; 2021 Jul; 36(4):109446. PubMed ID: 34320339
[TBL] [Abstract][Full Text] [Related]
19. Designer macrocyclic organo-peptide hybrids inhibit the interaction between p53 and HDM2/X by accommodating a functional α-helix.
Smith JM; Frost JR; Fasan R
Chem Commun (Camb); 2014 May; 50(39):5027-30. PubMed ID: 24710524
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous expression of MMB-FOXM1 complex components enables efficient bypass of senescence.
Kumari R; Hummerich H; Shen X; Fischer M; Litovchick L; Mittnacht S; DeCaprio JA; Jat PS
Sci Rep; 2021 Nov; 11(1):21506. PubMed ID: 34728711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]